Investigating the use of DAT-SPECT as an enrichment biomarker to determine eligibility for the phase 2 clinical trial PASADENA
Objective: Evaluate dopaminergic imaging DAT-SPECT as an enrichment strategy to avoid inclusion of participants with scans without evidence of dopaminergic deficit (SWEDD) in a Phase…Diagnosed and Drug-Treated Prevalence of Essential Tremor in Adult Patients: Retrospective Analyses of Two US Healthcare Claims Databases
Objective: Estimate the prevalence of diagnosed and drug-treated essential tremor (ET) in the adult population using 2 US healthcare claims databases. Background: ET is a…RE-EMERGENT TREMOR IN ESSENTIAL TREMOR; A PLUS SIGN FOR ET PLUS ?
Objective: This study aimed to investigate whether re-emergent tremor (RET) might also occur in essential tremor (ET) and if the cases with this additional sign…Neuroimaging in Glucocerebrosidase-associated parkinsonism: a systematic review
Objective: To critically review studies applying neuroimaging to Glucocerebrosidase (GBA)-associated parkinsonism. Background: Mutations in the GBA gene cause Gaucher disease (GD) and constitute the most…Psychiatric evaluation according to Brief Psychiatric Rating Scale-Expanded in patients with Parkinson’s disease
Objective: The aim of the study was to evaluate psychiatric manifestations of Parkinson’s disease (PD) and to establish statistical links with sociodemographic and clinical PD…Anti-IgLON5 mediated autoimmune encephalitis presenting with hemichorea
Objective: In the present case report, we aim to describe a patient suffering from a seldom autoimmune encephalitis presenting with isolated progressive hemichorea. Background: Anti-IgLON5…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.